Form 8-K - Current report:
SEC Accession No. 0001140361-25-038031
Filing Date
2025-10-14
Accepted
2025-10-14 07:10:18
Documents
30
Period of Report
2025-10-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20057029_8k.htm   iXBRL 8-K 79705
2 EXHIBIT 2.1 ef20057029_ex2-1.htm EX-2.1 825690
3 EXHIBIT 99.1 ef20057029_ex99-1.htm EX-99.1 97628
4 EXHIBIT 99.2 ef20057029_ex99-2.htm EX-99.2 31936
5 EXHIBIT 99.3 ef20057029_ex99-3.htm EX-99.3 37958
9 ef20057029_ex99-3slide1.jpg GRAPHIC 108958
10 ef20057029_ex99-3slide2.jpg GRAPHIC 336596
11 ef20057029_ex99-3slide3.jpg GRAPHIC 402256
12 ef20057029_ex99-3slide4.jpg GRAPHIC 130316
13 ef20057029_ex99-3slide5.jpg GRAPHIC 183751
14 ef20057029_ex99-3slide6.jpg GRAPHIC 167832
15 ef20057029_ex99-3slide7.jpg GRAPHIC 155660
16 ef20057029_ex99-3slide8.jpg GRAPHIC 103663
17 ef20057029_ex99-3slide9.jpg GRAPHIC 153962
18 ef20057029_ex99-3slide10.jpg GRAPHIC 156677
19 ef20057029_ex99-3slide11.jpg GRAPHIC 92411
20 ef20057029_ex99-3slide12.jpg GRAPHIC 110821
21 ef20057029_ex99-3slide13.jpg GRAPHIC 142764
22 ef20057029_ex99-3slide14.jpg GRAPHIC 131477
  Complete submission text file 0001140361-25-038031.txt   4711459

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20251014.xsd EX-101.SCH 3866
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20251014_lab.xml EX-101.LAB 21967
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20251014_pre.xml EX-101.PRE 16045
32 EXTRACTED XBRL INSTANCE DOCUMENT ef20057029_8k_htm.xml XML 4204
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 251389592
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)